Continue from research to sourcing
Compare MOTS-c listings without losing the evidence context
MOTS-c listings span multiple vial sizes, so headline prices can be misleading. PDD normalizes the labeled cost while keeping analytical evidence visible.
Identity first
Confirm the 16-amino-acid sequence, expected mass and exact offered amount. Endogenous biomarker research does not authenticate synthetic catalog material.
Normalize price
Compare the same vial amount or use price per mg; larger vials can have lower unit pricing despite a higher purchase price.
Inspect evidence
Look for lot-specific identity, purity and measured content, with clear laboratory and method information.
How MOTS-c is used in research
MOTS-c is encoded within mitochondrial 12S rRNA and was reported as a regulator of metabolic homeostasis in experimental systems.
Subsequent research has examined cellular stress responses, skeletal-muscle signaling, aging models, and associations or acute responses in human physiology.
Evidence map
Research stage matters. Findings from one model should not be silently promoted to another.
Laboratory
Cell studies examine metabolic and stress-response pathways.
Animal
Mouse models have explored metabolic homeostasis and physical performance.
Human
Small physiological and observational studies exist; therapeutic efficacy is unestablished.
What the evidence does not establish
The field is comparatively young. Assays, endogenous measurement, and exogenous test materials are not always directly comparable.
Study findings also do not authenticate a supplier’s material. Biological plausibility, a familiar name, or a published paper cannot substitute for lot-specific identity and quality evidence.
Analytical and documentation checks
The test plan should match the exact molecule, modification, and research question.
- Confirm the 16-amino-acid sequence and expected mass.
- Distinguish endogenous biomarker measurement from testing an exogenous synthetic peptide.
- Require lot-level identity, purity, and content documentation.
At minimum, connect the product name, sequence, sample identifier, lot, report, method, expected result, and observed result. Record untested attributes as “not reported,” not as assumed passes.
Build the documentation record
Regulatory status
MOTS-c is not an FDA-approved drug and is prohibited in sport under WADA’s non-approved substances category.
Regulatory status can change and attaches to specific products and jurisdictions. Verify current official records before publishing, procuring, or relying on a status claim.
Primary sources and official records
Use these records as starting points, then assess the exact model, test article, methods, and date:
Peptide Due Diligence Research Brief
Follow the evidence, not the headline.
Receive new evidence maps, documentation guides, and material corrections as the directory expands.
By subscribing, you agree to receive PDD research emails. Unsubscribe at any time.
Already subscribed? Get your free checklist.